The 30-Minute Medicine Problem

When a quick-commerce order for groceries goes out, the process is quick. An order is placed, it is assigned to a rider, the dark store fills a bag, a rider carries it to the door. The user opens the app, sees exactly the options that are available in the nearest dark store, and if one brand of biscuits is out of stock, picks from what is available. Or place the rest of the order, and whatever is left can be figured out later. The whole thing is optimised for one variable: Speed.

Now try running that same play with medicine.

"This is not bread and biscuits," says Gaurav Agarwal, Co-Founder at Tata 1mg. "These are medicines. There is a healthcare need of a patient, and they are depending on Tata 1mg to get it delivered in 30-60 minutes.The full prescription needs to be available, exactly as needed with everything as mentioned" The margin for error, he adds, collapses to nothing. "It is zero-tolerance, non-negotiable. We can't send one SKU less, or another SKU than what is in the prescription. All this with full compliance, adherence to required quality standards, and operated by qualified pharmacists who can understand the prescription with all its complexities"


That single line captures the work Tata 1mg has been making, largely out of public view, since 2024: that it can compress medicine delivery from a multi-day errand into a 30-to-60-minute promise, without breaking compliance, cold-chain and inventory constraints that make pharmacy a fundamentally different business from grocery. The service is now live in ten cities and the way the company has built it says a great deal about where India's ePharmacy market is heading next.

What it actually is — and what it isn't

The first thing to clear up is what Tata 1mg's quick commerce is not. It is not a standalone app, and it is not a marketplace tie-up bolted onto a horizontal player's rider fleet. "It's a new express delivery speed within the existing app," the company explains. "Given the complexity of the supply chain, and some of the requirements we impose on ourselves, we're doing it almost entirely in-house, adhering to the principles we follow and the regulatory requirements in this industry."

In practice that means a customer opens the same Tata 1mg app or web flow they already use, and in a serviceable location sees a faster delivery option surfaced against their order. Behind that option sits an operation the company has chosen to own rather than rent.

However, it is not a single delivery promise stretched across every healthcare need. In dense urban catchments, where inventory and order volumes are strong, 30-minute or one-hour delivery can work well. In other locations, same-day or next-day delivery is a more practical and sustainable starting point. As the retail network expands and demand and assortment strengthen, each catchment can gradually move towards faster delivery.

The service began as a single-city experiment in Gurgaon in 2024. Tata 1mg started piloting fast medicine delivery in Gurugram in 2024, which led to rapid growth in user acquisition & transacting users. “Speed in healthcare is meaningful only when it comes with certainty: the right medicine, the right handling and a reliable promise,” said Prateek Verma, Senior Vice President and Head of ePharmacy at Tata 1mg. “We are currently live with 30-minute delivery across 10 cities and are rapidly scaling our presence across markets. This year, New Delhi and Mumbai are among our key focus areas for deeper expansion, along with other cities. As our retail footprint, local assortment and last-mile network strengthen, we will progressively move more customers from multi-day waits to same-day, one-hour and 30-minute delivery.”

Why now: table stakes, and an asset to sweat

Three forces pushed Tata 1mg into the express tier - the first is that given customer behaviour change in categories like grocery etc, the expectation of customers is now to get all their needs faster. This has become table stakes, and a lot of consumers prefer not to plan. Second is the nature of the business. The pharmacy market is divided between Chronic, Acute, Symptomatic & Wellness. While the same day/ next day eCommerce model works fine for chronic & wellness categories, to serve the acute and symptomatic needs of consumers, which makes up ~50% of the market, the company needed a business model that could deliver faster, while ensuring its a viable sustainable model. Thirdly, given the company is anyway setting up physical retail across the major cities of India, it was well positioned to find a viable model to serve these needs better, and in an economically sustainable manner given the

An opportunity to synergise and sweat an asset through two business units instead of just a standalone," the company remarked. Layering a quick-commerce fulfilment role on top of the existing retail pharmacies improves the operationality of the store.

A supply chain with more legs

The medicine quick commerce is heavily reliant on the supply chain.

Grocery quick commerce is essentially a single relay: order placed, assigned to a picker, picked, handed to a rider, delivered. Pharmacy inserts a mandatory step before any of that can begin where the order goes to the doctor-prescription validation channel. A prescription-only medicine cannot move until a valid prescription has been uploaded or a valid consult conducted and that verification has to happen fast enough that the customer is not at the receiving end of this delay.

Three structural differences separate medicine quick commerce from the grocery version, and each one adds cost and constraint:

The first is the prescription itself. A prescription-only drug simply cannot be dispensed without a valid prescription.

The second is who does the dispensing. In grocery, any picker can pull the item. In pharmacy, the person dispensing a prescription medicine must be an authorised, certified pharmacist, checking that the right product reaches the right patient. This is where the zero-tolerance rule goes deeper than getting the molecule right. Patients are, in the team's telling, quite sticky to exactly what was prescribed. "Whatever the customer has ordered, whatever prescription is there, we are delivering the same medicine."

The third is compliance at the level of the building itself. Every node that processes medicines must hold a valid drug licence whereas a grocery dark store typically needs little beyond an FSSAI registration. Medicines must also be stored and transported separately, inside a dedicated enclosure within the store. That enclosure is not free: it demands additional capital expenditure, which lengthens the payback period on a pharmacy-enabled store relative to a plain grocery setup. Fast pharmacy, in other words, is structurally more expensive to stand up than fast grocery before a single order is delivered.

The cold chain that can't slip

Layered on top of all that is temperature. A meaningful slice of the catalogue is temperature-sensitive, and for those items the tolerances are exact. The cold chain needs to be maintained anywhere between 2 and 8 degrees Celsius. That requirement runs the length of the journey: dedicated refrigeration for storage, insulated cold boxes for transit, and monitoring to confirm the item stayed within bounds the entire way. Miss the window and the medicine can lose potency. A failure that, unlike a thawed tub of ice cream, has clinical consequences.

Interestingly, the last mile is where the two models converge. A rider's job is to collect the packet, deliver it intact is much the same whether the packet holds paracetamol or paneer, and grocery players already run cold delivery for chilled goods. What Tata 1mg layers on is training and a duty of care: riders are coached to treat the parcel as what it is. "We educate our riders that this is not bread, butter. These are medicines, where there is a healthcare need.”

The hardest problem is inventory

If cold chain and compliance are the visible complexities, the deepest one is invisible to the customer: deciding what to stock, where.

The scale of the challenge starts with the pharmacy itself. There are only some 3,000 to 4,000 active salts in the universe of Indian medicine but doctors can prescribe them in roughly 300,000 unique SKU combinations once you account for salt, strength, brand and manufacturer. And because patients are so loyal to the exact product they've always taken, demand for any single SKU is thin and spread across an enormous long tail. A missing variant isn't a shrug — it's a lost order.

Now compress that catalogue into the finite shelf space of a single store. Tata 1mg's full catalogue runs to hundreds of thousands of SKUs across prescription products and the remainder over-the-counter, wellness and non-prescription lines. A typical dark store can physically hold can serve only a slice of total demand as a single node, and the game becomes choosing the right slice.

And the right slice is intensely local. What sells is shaped, catchment by catchment, by which doctors and medical representatives are active in that pocket and it changes from neighbourhood to neighbourhood. For example, the mix that moves in Bengaluru's HSR Layout is not the mix that moves in BTM or near Bannerghatta. Getting this right can't be done from a spreadsheet in a head office; it needs "vast historical data and on-the-ground offline intelligence."

That is where a decade in the business becomes a defensible business opportunity. Tata 1mg runs an inventory engine that assigns a bespoke stock profile to each catchment. "Since we've been in this business for the last eleven years, we have enough data to see what kind of demand comes from which catchment," the company commented. The engine reads live signals including searches, clicks and orders by pin code and continuously refines what each node should carry. Crucially, this improves as the store network grows: more nodes generate more local data, and better data makes every node's inventory sharper. Retail expansion and quick-commerce quality move hand in hand.

The physical network underneath

The fulfillment layer is a deliberate mix rather than a single model. Tata 1mg leans overwhelmingly on its own in-house retail pharmacies, supplemented by its own dark stores, warehouses, and a tie-up with Big Basket for dark-store space in select locations.

On scale, the team offers directional figures with appropriate caution. The network comprises roughly 350 retail stores, which serve as fulfilment centres, with the broader fulfilment footprint expected to reach around 500 locations across major cities by the end of the year.

Coverage within a city is built patiently. Mumbai took time in "understanding the city from a geographical standpoint," building the retail colony and the network to cover the entire city within the next six to eight months. Beyond the metros, the company already has retail stores in a dozen tier-2 and tier-3 cities, with faster-than-standard service live in nine of them. There, "quick commerce" is better understood as a staircase than a single step: the near-term goal is to move customers from a multi-day wait to a multi-hour promise — same-day and few-hour windows — and then, node by node, down to the single-hour and 30-minute tier.

Making the unit economics work

As the company noted, "It's always a trade-off between what service level you want to give and at what cost. If you commit 30 minutes to everyone and want to deliver all the medicine within 30 minutes, you need to invest a lot — and that can be a dent to the P&L." The answer was a set of tolerances (a 30-to-35-minute operating band, for instance) that held service quality while keeping cost in check. That rulebook is what the company then carried into Bengaluru, Hyderabad and Mumbai — mostly tier-one markets, for now.

The model is deliberately density-led. Tata 1mg is not trying to force a 30-minute promise into every pin code, especially where the economics or service network cannot support it consistently. In healthcare, a slower promise that is reliably met is better than a faster one that breaks trust. Instead, each city is built through repeatable catchment-level playbooks. Store selection, local inventory, serviceability radius, last-mile performance and operating governance all have to work together to support faster fulfillment. Once that model works in one catchment, it can be replicated across a city and then carried into new markets. That is why speed follows density. It progresses from same-day to one-hour and eventually 30-minute delivery as the network becomes strong enough to support it.

The moat: compliance, data, and trust

Ask why a well-funded horizontal player couldn't simply replicate this, and the team's answer isn't about technology or capital. It's about accumulated, hard-won operating knowledge in a category that punishes shortcuts.

Three things are difficult to copy. The first is trust — the confidence that a medicine bought on the platform is genuine, built through years of positioning. The second is the decade of catchment-level demand intelligence that makes hyper-local inventory possible, and that a new entrant simply cannot conjure. The third is compliance fluency: knowing how the drug-licence, pharmacist and storage rules actually work in practice, across states with their own restrictions on what can be sold where. Horizontal quick-commerce players have looked hard at pharmacy; the regulatory and inventory nitty-gritties are, in his view, exactly what has kept the category from being an easy adjacency for them.

What comes next

The medicine express business is only one lane of a wider ambition. Tata 1mg continues to strengthen its service proposition by improving speed and convenience and scaling 30-minute delivery in select cities, enabling same-day delivery across more locations, and deepening its presence in newer categories such as pet care.

The same ethos extends across Tata 1mg’s healthcare services, from at-home diagnostics and vaccinations to initiatives such as six-hour report delivery in major cities.

But the throughline is the store network. Over the next three to five years, the company expects to operate several hundred stores across the country, and with each one, the zone of hour-and-under medicine delivery widens and the inventory engine gets smarter. The expansion of retail and the expansion of speed are, by design, the same project. New Delhi and Mumbai are among the important expansion markets this year. In parallel, Tata 1mg is building faster same-day and next-day pathways for additional cities using the appropriate combination of retail hubs and fulfilment centres.

In pharmacy, the winning promise is not simply the fastest delivery. It is the fastest delivery that can still get the right medicine to the customer safely, accurately and consistently. Speed alone is easy to replicate; the real advantage comes from the capabilities behind it like trusted sourcing, pharmacy expertise, prescription workflows, compliance, cold-chain discipline, assortment depth and hyperlocal demand intelligence.

For Tata 1mg, that means trust is not separate from quick commerce; it is what makes quick commerce valuable. A fast delivery only matters if the customer knows the medicine is genuine, handled correctly and exactly what was prescribed. That is why traceability and supply-chain quality are part of the same promise.